cysteine and AIDS Seroconversion

cysteine has been researched along with AIDS Seroconversion in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (70.00)18.2507
2000's2 (20.00)29.6817
2010's0 (0.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Datta, R; Hanna, LE; Manjunath, K; Roy Chowdhury, R; Varadarajan, R1
Foster, HD1
Borum, PR; Chance, M; Emgushov, RT; Jackson, JB; Kalayjian, RC; Mayer, KH; Skowron, G; Spell, SA; Webb, LS; Yen-Lieberman, B1
Dröge, W; Eck, HP; Mihm, S1
Altisent Roca, C; Arbós Via, MA; Juárez Giménez, JC; López Galera, RM; Montoro Ronsano, JB; Segura Cardona, RM; Tusell Puigbert, JM1
Gompels, M; Huengsberg, M; Moffitt, D; Round, R; Shahmanesh, M; Waring, R; Winer, J1
Breitkreutz, R; Dröge, W1
Agadjanyan, MG; Broliden, K; Burgess, A; Cao, C; Cotropia, JP; Dickey, C; Gevorkian, G; Larralde, C; Levi, M; Ugen, KE; Viveros, M; Weiner, DB1
Agy, MB; Coombs, RW; Corey, L; Frumkin, LR; Katze, MG; Koehler, J; Morton, WR; Wolinsky, SM1
Dröge, W; Eck, HP; Gmünder, H1

Reviews

1 review(s) available for cysteine and AIDS Seroconversion

ArticleYear
N-acetyl-cysteine in the therapy of HIV-positive patients.
    Current opinion in clinical nutrition and metabolic care, 1999, Volume: 2, Issue:6

    Topics: Acetylcysteine; Biological Availability; Cysteine; Glutathione; HIV Seropositivity; Humans; Sulfur

1999

Trials

1 trial(s) available for cysteine and AIDS Seroconversion

ArticleYear
A phase I/II trial of intravenous L-2-oxothiazolidine-4-carboxylic acid (procysteine) in asymptomatic HIV-infected subjects.
    Journal of acquired immune deficiency syndromes, 1994, Volume: 7, Issue:4

    Topics: Adult; Aged; beta 2-Microglobulin; CD4-Positive T-Lymphocytes; Cysteine; Female; Glutathione; HIV Seropositivity; Humans; Infusions, Intravenous; Leukocyte Count; Male; Middle Aged; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines

1994

Other Studies

8 other study(ies) available for cysteine and AIDS Seroconversion

ArticleYear
A facile method of mapping HIV-1 neutralizing epitopes using chemically masked cysteines and deep sequencing.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 11-24, Volume: 117, Issue:47

    Topics: AIDS Vaccines; Antibodies, Neutralizing; Antibody Formation; Antibody Specificity; Cell Line; Cysteine; env Gene Products, Human Immunodeficiency Virus; Epitope Mapping; Epitopes; HEK293 Cells; High-Throughput Nucleotide Sequencing; HIV Antibodies; HIV Infections; HIV Seropositivity; HIV-1; Humans; Immunization

2020
How HIV-1 causes AIDS: implications for prevention and treatment.
    Medical hypotheses, 2004, Volume: 62, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Cysteine; Glutamine; Glutathione; Glutathione Peroxidase; HIV Infections; HIV Seropositivity; HIV-1; Humans; Nutrition Disorders; Selenium; Tryptophan

2004
Oxidant-antioxidant status in human immunodeficiency virus infection.
    Methods in enzymology, 1994, Volume: 233

    Topics: Amino Acids; Antioxidants; Biomarkers; Cell Separation; Cells, Cultured; Culture Techniques; Cysteine; Cystine; Female; Glutamates; Glutamic Acid; Glutathione; HIV Infections; HIV Seropositivity; Humans; Indicators and Reagents; Lymphocytes; Male; Monocytes; Oxidants; Reference Values; Sex Characteristics; Spectrophotometry

1994
Glutathione and cysteine in HIV-infected hemophiliacs.
    Clinica chimica acta; international journal of clinical chemistry, 1996, Oct-15, Volume: 254, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Cysteine; Disease Progression; Female; Glutathione; Glutathione Disulfide; Hemophilia A; HIV Seropositivity; Humans; Male; Middle Aged

1996
Serum cysteine levels in HIV infection.
    AIDS (London, England), 1998, Jul-09, Volume: 12, Issue:10

    Topics: Adult; Cohort Studies; Cysteine; Follow-Up Studies; HIV Seronegativity; HIV Seropositivity; Homosexuality, Male; Humans; Male; Prognosis; Proportional Hazards Models; Survival Analysis

1998
Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41.
    Virology, 2000, Apr-25, Volume: 270, Issue:1

    Topics: Amino Acid Sequence; Amino Acid Substitution; Animals; Antibodies, Monoclonal; Antibody Specificity; Cell Line; Cysteine; Disulfides; HIV Antigens; HIV Envelope Protein gp160; HIV Envelope Protein gp41; HIV Seropositivity; HIV-1; Humans; Immune Sera; Immunodominant Epitopes; Molecular Sequence Data; Neutralization Tests; Peptides, Cyclic; Rabbits; Virus Replication

2000
Infection of Macaca nemestrina by human immunodeficiency virus type-1.
    Science (New York, N.Y.), 1992, Jul-03, Volume: 257, Issue:5066

    Topics: Animals; Base Sequence; CD4 Antigens; Cysteine; Databases, Factual; Genes, gag; HIV Infections; HIV Seropositivity; HIV-1; Humans; Lymphocytes; Macaca nemestrina; Methionine; Molecular Sequence Data; Oligodeoxyribonucleotides; Oligonucleotide Probes; Viral Proteins; Virus Replication

1992
Low membrane transport activity for cystine in resting and mitogenically stimulated human lymphocyte preparations and human T cell clones.
    European journal of biochemistry, 1991, Oct-01, Volume: 201, Issue:1

    Topics: Alanine; Arginine; Biological Transport; Cell Division; Cell Membrane; Cells, Cultured; Clone Cells; Cysteine; Cystine; Glutamates; Glutamic Acid; HIV Seropositivity; Humans; Lymphocytes; Methionine; Mitogens; Phytohemagglutinins; T-Lymphocytes

1991